F.D.A. Approves A.L.S. Treatment Despite Questions About Effectiveness

Health
By BY PAM BELLUCK from NYT Health https://ift.tt/2POrKbL
via IFTTT your-feed-science, Clinical Trials, Drugs (Pharmaceuticals), Amyotrophic Lateral Sclerosis, your-feed-healthcare The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.

Comments

Popular posts from this blog

Should the Autism Spectrum Be Split Apart?

The Jarring Contradiction at the Heart of Kennedy’s Agenda